Cargando…

Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)

Therapeutic nanofactories, which combine the features of nanoreactors and delivery carriers, are ideal for biomedical applications because of their enhanced therapeutic efficacy and reduced side effects compared to the conventional drug delivery system. In article number https://doi.org/10.1002/advs...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Tomoki, Akiyoshi, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247044/
http://dx.doi.org/10.1002/advs.201870067
_version_ 1783372433454006272
author Nishimura, Tomoki
Akiyoshi, Kazunari
author_facet Nishimura, Tomoki
Akiyoshi, Kazunari
author_sort Nishimura, Tomoki
collection PubMed
description Therapeutic nanofactories, which combine the features of nanoreactors and delivery carriers, are ideal for biomedical applications because of their enhanced therapeutic efficacy and reduced side effects compared to the conventional drug delivery system. In article number https://doi.org/10.1002/advs.201800801, Tomoki Nishimura and Kazunari Akiyoshi discuss the design strategies of therapeutic nanofactories with a focus on their use as therapeutics. [Image: see text]
format Online
Article
Text
id pubmed-6247044
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62470442018-11-26 Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018) Nishimura, Tomoki Akiyoshi, Kazunari Adv Sci (Weinh) Inside Front Cover Therapeutic nanofactories, which combine the features of nanoreactors and delivery carriers, are ideal for biomedical applications because of their enhanced therapeutic efficacy and reduced side effects compared to the conventional drug delivery system. In article number https://doi.org/10.1002/advs.201800801, Tomoki Nishimura and Kazunari Akiyoshi discuss the design strategies of therapeutic nanofactories with a focus on their use as therapeutics. [Image: see text] John Wiley and Sons Inc. 2018-11-21 /pmc/articles/PMC6247044/ http://dx.doi.org/10.1002/advs.201870067 Text en © 2018 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Inside Front Cover
Nishimura, Tomoki
Akiyoshi, Kazunari
Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title_full Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title_fullStr Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title_full_unstemmed Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title_short Therapeutic Nanofactories: Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories (Adv. Sci. 11/2018)
title_sort therapeutic nanofactories: biotransporting biocatalytic reactors toward therapeutic nanofactories (adv. sci. 11/2018)
topic Inside Front Cover
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247044/
http://dx.doi.org/10.1002/advs.201870067
work_keys_str_mv AT nishimuratomoki therapeuticnanofactoriesbiotransportingbiocatalyticreactorstowardtherapeuticnanofactoriesadvsci112018
AT akiyoshikazunari therapeuticnanofactoriesbiotransportingbiocatalyticreactorstowardtherapeuticnanofactoriesadvsci112018